# Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC)

> **NCT02968212** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Oregon Health and Science University** · enrollment: 102 (actual)

## Conditions studied

- Mycobacterium Avium Complex

## Interventions

- **DRUG:** Clofazimine
- **OTHER:** sugar pill

## Key facts

- **NCT ID:** NCT02968212
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-04-11
- **Primary completion:** 2025-08-29
- **Final completion:** 2026-10
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02968212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02968212, "Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02968212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*